CoChat

Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease

Open access
Rigauts, Charlotte, Aizawa, Juliana, Taylor, Steven L., Rogers, Geraint B., Govaerts, Matthias, Cos, Paul, Ostyn, Lisa, Sims, Sarah, Vandeplassche, Eva, Sze, Mozes, Dondelinger, Yves, Vereecke, Lars, Van Acker, Heleen, Simpson, Jodie L., Burr, Lucy, Willems, Anne, Tunney, Michael M., Cigana, Cristina, Bragonzi, Alessandra, Coenye, Tom, Crabbé, Aurélie · 2022 · European Respiratory Journal
Cited by 164

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background: Chronic airway inflammation is the main driver of pathogenesis in respiratory diseases such as severe asthma, chronic obstructive pulmonary disease, cystic fibrosis (CF) and bronchiectasis. While the role of common pathogens in airway inflammation is widely recognised, the influence of other microbiota members is still poorly understood. Methods: We hypothesised that the lung microbiota contains bacteria with immunomodulatory activity which modulate net levels of immune activation by key respiratory pathogens. Therefore, we assessed the immunomodulatory effect of several members of the lung microbiota frequently reported as present in CF lower respiratory tract samples. Results: We show that Rothia mucilaginosa, a common resident of the oral cavity that is also often detectable in the lower airways in chronic disease, has an inhibitory effect on pathogen- or lipopolysaccharide-induced pro-inflammatory responses,in vitro(three-dimensional cell culture model) and in vivo(mouse model). Furthermore, in a cohort of adults with bronchiectasis, the abundance of Rothia species was negatively correlated with pro-inflammatory markers (interleukin (IL)-8 and IL-1β) and matrix metalloproteinase (MMP)-1, MMP-8 and MMP-9 in sputum. Mechanistic studies revealed that R. mucilaginosa inhibits NF-κB pathway activation by reducing the phosphorylation of IκBα and consequently the expression of NF-κB target genes. Conclusions: These findings indicate that the presence of R. mucilaginosa in the lower airways potentially mitigates inflammation, which could in turn influence the severity and progression of chronic respiratory disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/13993003.01293-2021

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 164

Metadata

Authors
Rigauts, C., Aizawa, J., Taylor, S. L., Rogers, G. B., Govaerts, M., Cos, P., Ostyn, L., Sims, S., Vandeplassche, E., Sze, M., Dondelinger, Y., Vereecke, L., Van Acker, H., Simpson, J. L., Burr, L., Willems, A., Tunney, M. M., Cigana, C., Bragonzi, A., Coenye, T., & Crabbé, A.
Venue
European Respiratory Journal
Published
2021-09-29
Volume
59
Issue
5
Pages
2101293
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W3203379174
Cited by
164
References
8
FWCI
13.76
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease. https://app.cochat.ai/papers/10.1183/13993003.01293-2021
The paper
Rigauts, C., Aizawa, J., Taylor, S. L., Rogers, G. B., Govaerts, M., Cos, P., Ostyn, L., Sims, S., Vandeplassche, E., Sze, M., Dondelinger, Y., Vereecke, L., Van Acker, H., Simpson, J. L., Burr, L., Willems, A., Tunney, M. M., Cigana, C., Bragonzi, A., . . . Crabbé, A. (2022). Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease. European Respiratory Journal. https://doi.org/10.1183/13993003.01293-2021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.